PLUS THERAPEUTICS, INC. (PSTV)
About PLUS THERAPEUTICS, INC.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $5.2M
- Net income
- -$22.4M
- Total assets
- $16.3M
- Market cap
- $37.2M
- Operating margin
- -293.5%
- Net margin
- -429.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $5.2M
- Operating expenses
- $20.5M
- Operating income
- -$15.3M
- Income tax
- $0
- Net income
- -$22.4M
- EPS (basic)
- $-0.29
- EPS (diluted)
- $-0.29
Balance sheet
- Total assets
- $16.3M
- Current assets
- $15.2M
- Total liabilities
- $12.3M
- Current liabilities
- $12.3M
- Shareholders’ equity
- $4.0M
Cash flow
- Operating cash flow
- -$20.8M
- Investing cash flow
- -$854.0K
- Financing cash flow
- $30.3M
- Net cash flow
- $8.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $37.2M
- EPS (diluted)
- $-0.29
- Shares outstanding
- 9.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 16, 2000
Plus Therapeutics, Inc. (PSTV) Stock Price
- Reported a net loss of $22.4M in FY2025.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PLUS THERAPEUTICS, INC..
Write a review
News about PLUS THERAPEUTICS, INC.
News & sentiment via Polygon.io
Plus Therapeutics, Inc.: frequently asked questions
Is Plus Therapeutics, Inc. an American company?
Plus Therapeutics, Inc. is a US-based company headquartered in Austin, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Plus Therapeutics, Inc. headquartered?
Plus Therapeutics, Inc. is headquartered in Austin, Texas, United States.
Is Plus Therapeutics, Inc. publicly traded?
Yes — Plus Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol PSTV on the NASDAQ.
What does Plus Therapeutics, Inc. do?
Plus Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.
